Beam Therapeutics BEAM Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Beam Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.
The official record: Beam Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Beam Therapeutics's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Beam Therapeutics's short-term investments?
- Beam Therapeutics (BEAM) reported short-term investments of $923.36M in Q1 2026.
- How has Beam Therapeutics's short-term investments changed year-over-year?
- Beam Therapeutics's short-term investments increased by 33.4% year-over-year, from $692.05M to $923.36M.
- What is the long-term trend for Beam Therapeutics's short-term investments?
- Over 4 years (2020 to 2025), Beam Therapeutics's short-term investments has grown at a 62.1% compound annual growth rate (CAGR), from $137.5M to $950.27M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.